Skip to content

CORUM PHARMA

Active Private limited companyfounded 2021active for 5 yearsHeirweg 144 A, 8710 WielsbekeKBO/BCE: BE 0763.652.492

Lifetime

5 annual accounts with figures on one time axis
peak of €1.4m in 2022
€104,535▼ 6.7%
peak of €1.4m in 2022
€67,004▼ 7.5%
peak of €1.7m in 2026
€1.7m▲ 4.0%
€589,763▼ 11.2%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
26-10-20265 days before the deadline
2026abbreviated format
The year was quiet, with no large shift from the year before.

Key points

from the 2026 annual accounts

Equity

€1.7m ▲ 4.0%

CORUM PHARMA has made a profit in every financial year since 2022.

Turnover

≈ €160,000 estimated

The abbreviated format states no turnover.

Filings

5 annual accounts 1 late
deadline202220242026

The 2022 accounts came 3 days late. The other four were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • founderdeed of 17-02-2021
  • founderdeed of 17-02-2021

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0763652492
Incorporation Founding capital of €50,000 · Founded by and · (director) and (director) appointed · published on 17-02-2021 · Gazette deed
First establishment Heirweg 144 A, Wielsbeke
All 8 events

Comparable companies

same main activity, similar in size and age
Company
CORUM PHARMA Wielsbeke €2.3m €104,535 74.7% -
NGLG Roeselare €3.1m €97,255 91.9% -
HOLDING LORELLI Verlaine €2.3m €117,207 78.3% -
HSL HOLDING Pelt €2.1m €93,355 37.0% 0
BD TRANS Brunehaut €2.0m €108,834 67.7% -
QJD DEVELOPMENTS Etterbeek €2.6m €93,833 8.9% -
MARFIN HOLDING Boortmeerbeek €2.9m €102,369 91.9% -

These companies have the same main activity as CORUM PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €2m and €3.1m, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 15-02-2021Normal situation
Activity
Activities of holding companiesNACE 64210
Establishment unit
2.313.456.1368710 Wielsbeke, since 15-02-2021
Financial year end
31 March
Peppol
Reachable since 04-06-2025
Company details

Annual accounts to 31-03-2026

€2.3m▼ 0.3%
Filing
Filed on 26-10-2026, 5 days before the end of the filing period
Financials

Insights on CORUM PHARMA

CORUM PHARMA files the abbreviated format. That format states no turnover. The gross margin fell from €1.4m in 2022 to €104,535 in 2026.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CORUM PHARMA

What is the company number of CORUM PHARMA?
The company number of CORUM PHARMA is 0763.652.492. The VAT number is the same number with BE in front: BE 0763.652.492.
Where is CORUM PHARMA based?
The registered office is at Heirweg 144 A, 8710 Wielsbeke.Company details
What does CORUM PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of CORUM PHARMA?
CORUM PHARMA is a private limited company (BV).
When was CORUM PHARMA founded?
CORUM PHARMA was founded on 15-02-2021.
Is CORUM PHARMA still active?
Yes, CORUM PHARMA is an active enterprise in the KBO register.
What is the turnover of CORUM PHARMA?
The turnover in financial year 2026 is about €160,000. This figure is estimated from the gross margin of €104,535 and 34 comparable companies (NACE 64210). It probably lies between €140,000 and €200,000. In financial year 2022 turnover was €1.5m.Financials
Is CORUM PHARMA profitable?
In financial year 2026, CORUM PHARMA made a profit of €67,004.
Where can I find the annual accounts of CORUM PHARMA?
CORUM PHARMA filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of CORUM PHARMA due?
CORUM PHARMA must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.